Overcoming the Limitations of Conventional Cell Engineering

Murat Kalayoglu, president and CEO of Cartesian Therapeutics, discusses the company’s RNA-engineered cell therapies, how they work, and how the company is pushing the use of cell therapies beyond cancer.